Research graph
References from Genetic Yield and Imaging Characteristics in Apical-Dominant Hypertrophic Cardiomyopathy. Local targets link to admitted publications; unresolved targets remain external evidence.
2024 AHA/ACC/AMSSM/HRS/PACES/SCMR guideline for the management of hypertrophic cardiomyopathy
10.1016/j.jacc.2024.02.014 · 2024 · External reference
Long-term outcome in patients with apical hypertrophic cardiomyopathy
10.1016/s0735-1097(01)01778-8 · 2002 · External reference
Recommendations for multimodality cardiovascular imaging of patients with hypertrophic cardiomyopathy
10.1016/j.echo.2022.03.012 · 2022 · External reference
Role of genetic testing in diagnosis and prognosis prediction in hypertrophic cardiomyopathy in Korea
10.3346/jkms.2024.39.e313 · 2024 · External reference
Genotype-related clinical characteristics and myocardial fibrosis and their association with prognosis in hypertrophic cardiomyopathy
10.3390/jcm9061671 · 2020 · External reference
Unravelling the genotype of the apical variant of hypertrophic cardiomyopathy in a Swedish cohort
10.3390/genes16050494 · 2025 · External reference
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
10.1038/gim.2015.30 · 2015 · External reference
Development and validation of automated methods for quantifying late gadolinium enhancement in cardiac MRI for hypertrophic cardiomyopathy
10.1016/j.jocmr.2024.101439 · 2025 · External reference
Genotype and lifetime burden of disease in hypertrophic cardiomyopathy: insights from the Sarcomeric Human Cardiomyopathy Registry (SHaRe)
10.1161/circulationaha.117.033200 · 2018 · External reference
Quantitative late gadolinium enhancement cardiac magnetic resonance and sudden death in hypertrophic cardiomyopathy: a meta-analysis
10.1016/j.jcmg.2023.07.005 · 2024 · External reference
